Back
Acumen Pharmaceuticals Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
ABOS
Acumen Pharmaceuticals
Last Price:
$1.18
Seasonality Move:
-12.02%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight selling pressure.
Acumen Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Sell |
| 20-day SMA: | 1.23 | Sell |
| 50-day SMA: | 1.39 | Sell |
| 200-day SMA: | 2.23 | Sell |
| 8-day EMA: | 1.21 | Sell |
| 20-day EMA: | 1.25 | Sell |
| 50-day EMA: | 1.42 | Sell |
| 200-day EMA: | 2.2 | Sell |
Acumen Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 41.93 | Sell |
| Chaikin Money Flow: | -18751 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.31) | Sell |
| Bollinger Bands (100): | (1.28 - 2.38) | Sell |
Acumen Pharmaceuticals Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Acumen Pharmaceuticals Stock
Is Acumen Pharmaceuticals Stock a Buy?
-
Acumen Pharmaceuticals share price is 1.19 while ABOS 8-day simple moving average is 1.21, which is a Sell signal.
-
The stock price of ABOS is 1.19 while Acumen Pharmaceuticals 20-day SMA is 1.23, which makes it a Sell.
-
Acumen Pharmaceuticals 50-day simple moving average is 1.39 while ABOS share price is 1.19, making it a Sell technically.
-
ABOS stock price is 1.19 and Acumen Pharmaceuticals 200-day simple moving average is 2.23, creating a Sell signal.
ABOS Technical Analysis vs Fundamental Analysis
Sell
18
Acumen Pharmaceuticals (ABOS)
is a Sell
Is Acumen Pharmaceuticals a Buy or a Sell?
-
Acumen Pharmaceuticals stock is rated a SellThe current Acumen Pharmaceuticals [ABOS] share price is $1.19. The Score for ABOS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Acumen Pharmaceuticals Stock Info
Market Cap:
71.5M
Price in USD:
1.19
Share Volume:
118.8K
Acumen Pharmaceuticals 52-Week Range
52-Week High:
4.28
52-Week Low:
1.10
Sell
18
Acumen Pharmaceuticals (ABOS)
is a Sell
Acumen Pharmaceuticals Share Price Forecast
-
What is the Acumen Pharmaceuticals stock price today?The Acumen Pharmaceuticals stock price is 1.19 USD today.
-
Will ABOS stock go up or go down?Acumen Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Acumen Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acumen Pharmaceuticals is overvalued.
Is Acumen Pharmaceuticals Stock a Buy?
-
Acumen Pharmaceuticals share price is 1.19 while ABOS 8-day exponential moving average is 1.21, which is a Sell signal.
-
The stock price of ABOS is 1.19 while Acumen Pharmaceuticals 20-day EMA is 1.25, which makes it a Sell.
-
Acumen Pharmaceuticals 50-day exponential moving average is 1.42 while ABOS share price is 1.19, making it a Sell technically.
-
ABOS stock price is 1.19 and Acumen Pharmaceuticals 200-day simple moving average is 2.20, creating a Sell signal.
Fundamental Analysis of Acumen Pharmaceuticals
Is Acumen Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.90 per share, and an increase next year of $0.35 per share.
Technical Analysis of Acumen Pharmaceuticals
Should I short Acumen Pharmaceuticals stock?
-
ABOS Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Acumen Pharmaceuticals is a Sell
-
Acumen Pharmaceuticals Relative Strength Index (RSI) is 41.93, which suggest Acumen Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Acumen Pharmaceuticals is (1.19 - 1.31), which suggest Acumen Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Acumen Pharmaceuticals is (1.28 - 2.38), which suggest Acumen Pharmaceuticals is a Sell
* Acumen Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.